Biodentine Pulpotomy vs Metapex Pulpectomy in Primary Molars: Clinical & Radiographic Comparison of Outcomes in Irreversible Pulpitis Cases
Clinical and Radiographic Evaluation of Calcium Silicate Cement (Biodentine) Used As A Pulpotomy Agent In Primary Molars With Irreversible Pulpitis Versus Pulpectomy Using Calcium Hydroxide Iodoform Paste (Metapex)
1 other identifier
interventional
28
1 country
1
Brief Summary
Irreversible pulpitis is defined as a clinical diagnostic based on subjective and objective findings suggesting that the vital inflamed pulp is incapable of healing in the American Association of Endodontists (AAE) Consensus Conference Recommended Diagnostic Terminology. Other characteristics include persistent heat discomfort, transferred pain, spontaneous pain, or no clinical symptoms but caries-induced inflammation, caries excavation, and trauma.". Dental caries is one of the most frequently occurring diseases affecting human beings that becomes a challenge for dentists as the disease progresses. The ultimate goal of operative and endodontic treatment is to preserve and maintain the vitality of pulp to allow continued development of odontogenic apparatus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 29, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedMarch 24, 2026
March 1, 2026
11 months
July 24, 2024
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Radiographic
Radiographic Furcation involvement: Furcation involvement will be assessed radiographically using DIGORA software, with visual interpretation assigning scores based on radiolucency levels: 0 for no radiolucency; 1 for radiolucency affecting up to ¼ of the furcation area extending towards the periapical region; 2 for radiolucency involving between ¼ and ½ of the furcation area extending towards the periapical region; and 3 for radiolucency affecting more than ½ of the furcation area extending towards the periapical region.
Twelve Months
Secondary Outcomes (1)
Clinical
Twelve Months
Study Arms (2)
Metapex
ACTIVE COMPARATORPartial pulpectomy using Calcium Hydroxide with Iodoform (Metapex ) in carious primary molars with irreversible pulpitis
Biodentine
EXPERIMENTALPulpotomy using Biodentine in carious primary molars with irreversible pulpitis
Interventions
Biodentine: A dental pulpotomy treats tooth decay or trauma in primary and young permanent teeth by removing infected pulp tissue in the crown while preserving healthy root pulp. The procedure involves anesthesia, decay removal, pulp chamber access, hemostasis, and applying a medicament like MTA or Biodentine. The tooth is then restored with a filling, often a stainless steel crown. Pulpotomies preserve tooth structure, relieve pain, and are less invasive than full root canals, but require regular follow-up.
Metapex: A dental pulpectomy treats tooth with irreversible pulpitis in primary and teeth by removing infected pulp tissue using files and irrigation in the radicular part. The procedure involves anesthesia, decay removal, pulp chamber access, filing and irrigation till we reach cleaned dried canals and applying a medicament like Metapex . The tooth is then restored with a filling, often a stainless steel crown. The loss of pulp tissue weakens the tooth's structure and increases the risk of fracture and infection.
Eligibility Criteria
You may qualify if:
- Patient and parent showing cooperation and compliance.
- Children 4-9 years old
- Vital deeply carious primary(s) with complete root formation
- Asymptomatic teeth or without clinical symptoms of spontaneous pain
- No clinical evidence of pulp degeneration like the history of spontaneous or nocturnal pain, tenderness to percussion, pathologic tooth mobility, swelling, or fistulous tract.
- Both genders will be included.
- No radiographic evidence of pulp degeneration such as internal root resorption, external root resorption, or furcal radiolucency.
- Presence of 2/3rd of root
- Teeth that can be restored
- Children with prior parental consent.
You may not qualify if:
- soft tissue inflammation.
- tooth mobility.
- sinus tract.
- Any radiographic sign of periapical pathologies or pulp necrosis (periapical radiolucency, internal or external root resorption)
- History of any systemic disease
- Teeth showing clinical or radiographic evidence of pulp degeneration
- Hemostasis not achieved within 5 minutes of pulp amputation, by direct contact with a wet cotton pellet before the material placement
- The remaining radicular tissue was non-vital (with suppuration or purulence necrosis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marwa Salamoon, Ph.D
Lecturer of Pediatric Dentistry and Dental Public Health MSA University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
July 24, 2024
First Posted
July 29, 2024
Study Start
October 1, 2024
Primary Completion
September 1, 2025
Study Completion
September 15, 2025
Last Updated
March 24, 2026
Record last verified: 2026-03